Scientific breakthrough could offer melanoma cure

London, May 16 (ANI): A long-awaited jab, being hailed as a scientific breakthrough which could offer a cure for cancer, is to be tested on the first British patients within weeks.

According to researchers, it can reverse and even cure melanoma, one of the deadliest forms of the disease, most commonly associated with skin cancer, reports The Daily Express.

Professor Lindy Durrant of Nottingham University, who is heading research into the treatment, said: “This is huge. We could now have a vaccine that can target a tumour and kill it without damage to surrounding healthy tissues or cells.

“In the short term, this could cure some patients with the disease and in the long term the jab could be used to prevent people developing it in the first place.”

Trials will begin at hospitals in Manchester, Nottingham and Newcastle.

Brainchild of vaccine company Scancell, the treatment will be given to patients with advanced skin cancer which has spread to other parts of the body, and also to those in the earlier stages of the disease. (ANI)

Protein jab mends broken bones

London, May 10 (ANI): Scientists have found a novel way to significantly speed up the healing of broken bones in mice, a feat which, if replicated in humans, could mean people with fractures would be free of their casts a lot sooner.

Jill Helms, Roel Nusse and team at Stanford University in California drilled small holes into the shin bones of mice, and injected them with Wnt proteins.

These proteins prompt bone stem cells to divide, reports New Scientist.

Three days later, bone growth was three times greater than in mice injected with a placebo, it was observed.

The approach could prove to be better than adding new stem cells, which can divide uncontrollably.

The research has appeared in the journal Science Translational Medicine. (ANI)

1 in 4 Brit men prefer fake boobs to natural ones

London, March 22 (ANI): A quarter of men have a liking for artificial enhancements when compared to natural breasts, according to a new British poll.

The survey for MyFaceMyBody.com found a third were happy to foot the bill for a partner”s breast enlargement.

Researchers also found that more than half (55 per cent) of women wanted to change the size or shape of their assets while two in five would not mind surgery to flatten their stomachs, The Sun reported.

Nine in ten also said they would prefer a non-surgical procedure, such as the new “boob jab” injections, over traditional implants.

MyFaceMyBody spokesman Stephen Handisides said: “We hadn”t realised such a high percentage of women are dissatisfied with their bust size and are so keen to do something about it.” (ANI)

Natural hydrogel may boost spinal cord healing

Washington, Sep 18 (ANI): A jab of biomaterial gel into a spinal cord injury site may significantly improve healing, according to researchers at the Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center.

Dr. Mark Preul and Dr. Alyssa Panitch have found in a study that injection of an engineered hydrogel made up mainly of hyaluronic acid (a naturally-occurring body substance) into the spinal cord injury site decreases scarring, and promotes a realignment of the spinal cord fibres around the injury site.

The hyaluronic acid, which forms a scaffold-like configuration may help to structurally stabilize the spinal cord injury site.

The researchers traced cells in the brain stem after injury, and found much higher levels in the hydrogel treated animals as compared to animals that did not receive the treatment, and approached nearly normal levels.

Treated animals had higher functional scores than their non-treated counterparts.

“Spinal cord injury is devastating to civilian and military populations – especially to the young. There has been little progress toward paradigms of regeneration and few results that show real, sustained functional recovery. We’ve been so pre-occupied with regeneration, but that is a highly complicated and difficult to define goal. This project is a synergy of neurosurgeons and bioengineers that attempts repair of the SCI lesion cavity using a tissue-engineering biomaterials approach,” says Preul.

He added that the team aimed at finding ways to structurally allow the body to better heal itself.

“In this project we did not add anything to the hyaluronic acid. It may be that adding growth factors or cells into the gel matrix may allow even better results,” he said.

Preul said that the results show “we may be on a practical path that can give hope to the many people who suffer this sort of injury.”

The work was presented at the Annual Meeting of the American Association of Neurological Surgeons in San Diego where it won the Synthes Prize for Spine Research. (ANI)

Bhajji uses blog to defend his jab at ANI cameraman

Colombo, Sep.10 (ANI): Off spinner Harbhajan Singh used his blog on Thursday to defend his jabbing of an ANI cameraman at the Bangalore International Airport on Wednesday.

Bhajji said that he did not slap any cameraperson. He also said that he would never do that as he respects the media and always cooperates with them.

He also said he is focusing on taking the team in attaining the top spot by winning the tri series in Colombo.

Harbhajan jabbed at the photographer after his camera glanced his turban while he was unloading his luggage.

He gave an angry stare at the cameraman even as a security personnel tried to push back the lensmen who had virtually mobbed the cricketer. (ANI)

Soon, simple jab to prevent prostate cancer

Washington, Sept 8 (ANI): A simple jab may soon help prevent prostate cancer, say researchers.

The research team from University of Utah and University of Columbia have identified a virus, known to trigger leukaemia, in malignant human prostate cancer cells.

The research team hopes that the virus, XMRV (Xenotropic murine leukemia virus-related virus), would open opportunities for developing diagnostic tests, vaccines, and therapies for treating the cancer.

“We found that XMRV was present in 27 percent of prostate cancers we examined and that it was associated with more aggressive tumours,” said Dr Ila R. Singh, associate professor of pathology at University of Utah and the study’s senior author.

“We still don’t know that this virus causes cancer in people, but that is an important question we’re going to investigate,” Singh added.

The study also makes it evident that XMRV is present in malignant cells, and that XMRV is a gammaretrovirus, a simple retrovirus first isolated from prostate cancers in 2006 by researchers at the University of California, San Francisco (UCSF), and the Cleveland Clinic, known to cause cancer in animals.

During the study, the researchers examined more than 200 human prostate cancers, and compared them to more than 100 non-cancerous prostate tissues.

They found 27 percent of the cancers contained XMRV, compared to only 6 percent of the benign tissues.

The viral proteins were found almost exclusively in malignant prostatic cells, suggesting that XMRV infection may be directly linked to the formation of tumors.

The study is published in the Proceedings of the National Academy of Sciences. (ANI)

55th National Awards announced: Gandhi, My Father wins two

New Delhi, Sep.7 (ANI): The Anil Kapoor produced film ‘Gandhi, My Father’ has won two National Awards while the Shahrukh-starrer ‘Om Shanti Om’ has won in the Best Art Direction category, and Shahid Kapur-starrer ‘Jab We Met’ won the award in Best Choreography category in the 55th National Awards that were announced on Monday.

Gandhi, My Father was pitted against commercial successes like Taare Zameen Par and Chak De.

Feroz Abbas Khan, the director of the Gandhi, My Father won the National Award for Best Screenplay and Darshan Zariwala bagged theaward for the Best Supporting actor for portraying Mahatma Gandhi, the Father of the Nation who strives hard to have a normal relationship with his son in the film.

Meanwhile, actor Prakash Raj has won the Best Actor award in the 55th National Awards for his sterling performance as a silk weaver in Priyadarshan’s Tamil film Kanchivaram, which has been adjudged as the Best Film of 2007.

“It’s a very human story of pre-partition time about Kanjivaram. The film’s script was written so well that I didn’t require any homework. It is

It is Prakash Raj’s second National award. The previous one was in the Best Supporting Actor category for Mani Ratnam’s Iruvar in 1998 and a special jury award in 2003.

Directed by Priyadarshan, the film depicts the lives and times of silk-weavers of Kancheepuram in pre-Independent India.

Actor Umashree has won the Best Actress award for her performance for her lead role ‘Gulabi’ in Girish Kasaravalli’s Kannada film “Gulabi Talkies”.

The Gulabi Talkies, which was made in the coastal dialect of Kannada is based on the communal tension in Karnataka.

The best child actor award has gone to Sharad Goyekar for his role in the Marathi film “Tingya”.

Darshan Zariwala has got the best supporting actor award for his role in Feroz Abbas Khan’s film “Gandhi My Father”.

There is also a special jury award for this film, which explores the troubled relationship between Harilal Gandhi and Mahatma Gandhi.

“Chak De” has got the award in the wholesome entertainment category and “Taare Zameen Par” in the family welfare category.

Playback singer Shankar Mahadevan has won the award for the song “Meri Maa” from the film “Taare Zameen Par”.

The jury members for the National Awards headed by Sai Paranjpe included Ashok Viswanathan and Namita Gokhale. About 102 films and 106 non-feature films were considered.

The list had been finalized last week but because of the death of Andhra Pradesh chief minister YSR Reddy, the announcement was postponed. (ANI)

Painless ‘microneedle’ patch may end jab fear

Washington, Aug 20 (ANI): Scientists at the Georgia Institute of Technology have designed a painless patch that may someday make hypodermic needles as well as annual flu shots a thing of the past.

These patches, lined with tiny ‘microneedles,’ could make treatment of diabetes and a wide range of other diseases safer, more effective and less painful, according to the researchers.

Used as tiny hypodermic needles, they could improve treatment of macular degeneration and other diseases of the eye.

“It’s our goal to get rid of the need for hypodermic needles in many cases and replace them with a patch that can be painlessly and simply applied by a patient,” said Mark Prausnitz from the Georgia Institute of Technology.

“If you can move to something that’s as easy to apply as a band-aid, you’ve now opened the door for people to self-administer their medicine without special training,” he added.

Prausnitz said that advances in the electronics industry in microfabricating very small objects like transistors enabled the development of microneedles.

“We’ve built off those technological advances to address a need in medicine. We’re trying to bring the two worlds together,” he said.

Each needle is only a few hundred microns long, about the width of a few strands of human hair.

Prausnitz and his colleagues suggest that the microneedle patch could, for instance, replace yearly trips to the doctor for flu shots.

In a collaboration with Emory University, Prausnitz and his team administered flu vaccines via conventional injections and microneedle patches in mice.

After exposing the mice to the flu, they compared the resulting immune response and antibody levels. They found that the antibody levels were the same by either route.

Taking a closer look, they discovered that microneedle delivery resulted in a better protective immune response by other measures.

“Toward the goal of a flu vaccine patch, we are continuing the animal studies, but we’re also working toward our first human trial, which we hope to do in 2010,” Prausnitz said.

Microneedles are not just able to deliver drugs through the skin they can also be used for targeted drug delivery in the eye.

They may help create an improved treatment for macular degeneration.

The study has been presented at the 238th National Meeting of the American Chemical Society. (ANI)

Gordan Ramsay admits using Botox

London, July 5 (ANI): Celebrity chef Gordan Ramsay has admitted to using Botox.

The 42-year-old admitted that he turned to Simon Cowell’s doctor for a facelift.

“I’ve always had a face like Freddy Krueger but more and more people were commenting on my chin,” the Daily Star quoted him as saying.

“A make-up artist actually said to me, ‘Did you have an accident when you were little? Did you fly through the windscreen with no seat belt on?’ I mean f**k!” he added.

However, it was Cowell’s comments that forced Ramsay to have Botox.

He said: “I had lunch with him and he leaned over and started prodding my chin, saying, ‘Mate you’ve got to do something about this’.

“I was like, ‘F**k off!’ I was getting a complex for the first time in my life, so I did it. Botox. A jab here and one there.” (ANI)

Kisses and expletives, but ‘Love Aaj Kal’ a family film: Director

Kisses and expletives, but ‘Love Aaj Kal’ a family film: Director

Joginder Tuteja Mumbai, July 5 (IANS) Imtiaz Ali openly admits that his upcoming “Love Aaj Kal”, which stars Saif Ali Khan and Deepika Padukone, has unabashed kissing scenes and shows the lead actors mouthing expletives, but the director insists that it will still be a complete family entertainer.

The director says he has included the so-called objectionable scenes in the movie’s promos so that people are already used to it by the time they see the film.

“See, it’s the way you put it in the film and treat it. It’s up to the filmmaker not to make his film some fodder for perversion or lechery.” Ali told IANS.

Ali promises that “Love Aaj Kal”, which is Saif’s production debut, is a film that would be accepted by an entire family.

“Kisses included,” he winks. “Nobody will feel inhibited watching ‘Love Aaj Kal’. No one will hesitate walking into the film with his family. All that is potentially objectionable in the film in the strictest of sense has been taken care of in the first promo. If you have warmed up on it, rest assured you will love ‘Love Aaj Kal’,” the filmmaker said.

“Love Aaj Kal” is his third love story after “Socha Na Tha” and the blockbuster “Jab We Met”.

But there were people around Ali who weren’t too comfortable with the idea of showing Saif trying to hold Deepika’s butt, then share an unabashed kiss with her in the car and also mouth Hinglish expletives on a date right in the promo itself.

“They thought that people may get an impression that the film was only about these things but I had my own viewpoint,” explains Ali.

“My argument is that audiences are really smart. They pretty much see the intention of the filmmaker and make up their mind to watch the film accordingly. We better start taking them seriously rather than attempt at fooling them by considering ourselves over smart,” he says.

To substantiate his claim, Ali goes on to share an anecdote from his experience during the making of “Jab We Met”, which starred Shahid Kapoor and Kareena Kapoor.

“Remember the sequence in the second half of the film when Kareena curses her ex-boyfriend on phone? She goes on to say ‘Teri Maa Ki’ and a lot more. Did the audience feel awkward? Not at all. In fact they laughed during the entire scene and not a single soul came and told me that he/she felt offended by the language,” Ali reasons.

The director, however, admits that for “Love Aaj Kal”, the prime target audience is the younger crowd.

“And that’s more by accident rather than planned,” he says. “The film caters to them mainly because it’s this age group that goes and sees films in theatres. Due to this, even when I am conceptualising a film and then putting it on celluloid, I feel safe from my target audience perspective,” he explains.

With music by Pritam and lyrics by Irshad Kamil, “Love Aaj Kal” is set for a July 31 release.

Music of ‘Love Kal Aaj’ launched in Mumbai

Mumbai, June 28 (ANI): The music launch of the Bollywood film ‘Love Kal Aaj’, a story about relationships, took place in Mumbai on Saturday.

Saif Ali Khan is the lead actor and co-producer of the film, while ‘Jab We Met’ fame Imtiaz Ali is directing the flick.

Saif Ali Khan spoke at length about the problem of music piracy.

“I would love to tell everyone that you should try to get the music which we have created and sold and not the version that is on the net, it is not the proper version. Here is the music which we intended you to hear it and piracy is stealing and it is wrong and it’s a big problem and I hope people don’t do it and I still hope that people will still prefer to get an original CD and listen to it then get a very bad version on the net,” said Khan.

The film also stars Deepika Padukone, Neetu Singh, Rishi Kapoor and Rahul Khanna.

While speaking to the media at the music release of the film, actor Deepika Padukone said: “I think Zee Sa Re Ga Ma is a great platform to have had our music launch because it has a wide reach and the people all over the world see it and you have extremely talented singers and lot of the people grow up to become playback singers for our films so I thought it was a good experience and fun to see such young talent.”

Pritam Chakraborty has composed the music of the film, while Irshad Kamil has penned the lyrics.

The film is slated for a July 31 release. (ANI)

KP claims gruelling fitness regime caused his Achilles injury

London, June 28 (ANI): England middle-order bat Kevin Pietersen has said that his gruelling self-imposed Caribbean fitness regime caused his Achilles injury.

With the First Test against Australia just 10 days away, Pietersen is still not 100 per cent fit.

According to News of The World, Pietersen has already had a cortisone jab injected into the nerve in his spine to treat the injury.

He admits that too much running during England’s winter tour of the West Indies fuelled his current fitness problems.P’s personal training schedule included:

.3.5mile sprints on a treadmill the night before Test matches.

.Running six miles from the ground in St Kitts to the England hotel instead of catching the team bus.

. Mile-long shuttle runs up and down hills near the team hotel.

“Road running is what I absolutely love, but I did too much. I was doing huge runs in the Caribbean – too much – which hurt my back and was linked to the problems I’ve since had,” he was quoted, as saying.(ANI)

Now, painless nanoneedles to deliver drugs to cell organelles directly

Washington, May 23 (ANI): Always dreaded those moments when the doctor got that syringe ready to painfully jab it into your arm? Well, not anymore, for scientists have now designed gold-plated nanoneedles that can deliver the medicine right into the tiny organs of cells and that too without causing any pain.

Thinner than a human hair, the new nanoneedle distributes molecules directly to the right organelles, doing away with the problem of the cell organelles’ failure to collect and use drugs released into the bloodstream.

“What we have here, is a powerful tool for delivering a very tiny amount of drugs into cells that have initially been removed from the body and can-after being injected by the nanoneedle-be placed back into the body for tracking, diagnosing, and treatment of illness,” National Geographic News quoted study co-author Min-Feng Yu, a University of Illinois molecular biologist, as saying.

However, the idea of a nanoneedle isn’t as new as it seems, for scientists have long been trying to use tiny syringes to inject cells.

But needles, developed earlier, have been relatively clumsy, damaging cells as they poked them.

Thus, to avoid building a squirting tube, the researchers designed a solid needle that didn’t need to be hollow and was cell-friendly 50 nanometres wide.

Tiny particles are attached to the nanoneedle’s thin outer layer of gold via “linker” particles. After entering an organelle, the nanoneedle releases the particles.

The researchers have said that designing nanoneedles that can be programmed to target multiple cells and automatically deliver drugs into those cells at the same time, could mean that there may be a day when nanoneedles needn’t be rocket science.

The findings have been published online by the journal Nano Letters. (ANI)

Like humans, goldfish too feel pain

London, May 01 (ANI): A team of researchers has claimed to have solved the mystery that intrigued the science world for decades: Whether or not fish feel pain?

And, the answer is yes. Just like humans, goldfish feel pain too.

Whilst the marine creatures can be seen to react to a jab or blow, experts have disagreed over whether the reaction indicates a sensation of pain, or is little more than a basic reflex.

Therefore, researchers, from Norway and the US, embarked on a study to set the record straight.

In the experiment, goldfish were exposed to painful heat. Half of the fish were given a painkilling injection of morphine beforehand, while the other half were not.

Two hours later, the fish that had undergone the test without painkillers showed signs of fear and wariness – suggesting that they had suffered a bad experience and remembered it, say researchers.

According to scientists, the finding undermines claims that fish merely display reflex actions and do not sense pain.

“The results show that it could not have been a simple reflex action,” The Telegraph quoted Dr Joseph Garner, as saying.

“The fact that their behaviour changed so much really strongly suggests there is something going on with their memory and experience of that event that is not a reflex. I believe it does show that fish feel pain,” he added.

The work was carried out by Janicke Nordgreen with colleagues at the Norwegian School of Veterinary Science and Purdue University. The findings are reported in the journal Applied Animal Behaviour Science. (ANI)

Goldfish feel pain too

London, Apr 26 (ANI): A team of researchers has claimed to have solved the mystery that intrigued the science world for decades: Whether or not fish feel pain?

And, the answer is yes. Just like humans, goldfish feel pain too.

Whilst the marine creatures can be seen to react to a jab or blow, experts have disagreed over whether the reaction indicates a sensation of pain, or is little more than a basic reflex.

Therefore, researchers, from Norway and the US, embarked on a study to set the record straight.

In the experiment, goldfish were exposed to painful heat. Half of the fish were given a painkilling injection of morphine beforehand, while the other half were not.
Two hours later, the fish that had undergone the test without painkillers showed signs of fear and wariness – suggesting that they had suffered a bad experience and remembered it, say researchers.

According to scientists, the finding undermines claims that fish merely display reflex actions and do not sense pain.

“The results show that it could not have been a simple reflex action,” The Telegraph quoted Dr Joseph Garner, as saying.

“The fact that their behaviour changed so much really strongly suggests there is something going on with their memory and experience of that event that is not a reflex. I believe it does show that fish feel pain,” he added.

The work was carried out by Janicke Nordgreen with colleagues at the Norwegian School of Veterinary Science and Purdue University. The findings are reported in the journal Applied Animal Behaviour Science. (ANI)

Anaesthesia jab promises prolonged pain relief without toxicity

Washington, April 16 (ANI): A single injection may soon revolutionise the treatment of pain during and after surgery, thanks to a promising slow-release anesthetic drug-delivery system developed by researchers at Children’s Hospital Boston.

During an NIH-funded study, the researchers used specially designed fat-based particles called liposomes to package saxitoxin, a potent anesthetic, and produced long-lasting local anesthesia in rats.

The team revealed that the procedure did not seem to leave any toxic effects on nerve or muscle cells.

“The idea was to have a single injection that could produce a nerve block lasting days, weeks, maybe even months,” says Dr. Daniel Kohane, of the Division of Critical Care Medicine in the Department of Anesthesiology at Children’s, and the report’s senior author.

“It would be useful for conditions like chronic pain where, rather than use narcotics, which are systemic and pose a risk of addiction, you could just put that piece of the body to sleep, so to speak,” he added.

Kohane and his colleagues have found that when saxitoxin is packaged within liposomes, it is able to block nerve transmission of pain without causing significant nerve or muscle damage.

The researchers evaluated various types of liposomes containing saxitoxin with or without dexamethasone, a potent steroid known to augment the action of encapsulated anesthetics. They found that the best liposomes produced nerve blocks lasting two days if they contained saxitoxin alone, and seven days if combined with dexamethasone.

Upon cell culture experiments and tissue analysis, it became clear that the formulations were not toxic to muscle or nerve cells.

The researchers even examined expression of four genes known to be associated with nerve injury, and found no up-regulation.

“If these long-acting, low-toxicity formulations of local anesthetics are shown to be effective in humans, they could have a major impact on the treatment of acute and chronic pain. This slow-release technology may also have broader applications in drug delivery for the treatment of a variety of diseases,” says Dr. Alison Cole, of the NIH’s National Institute of General Medical Sciences, which partially funded the work.

Kohane’s team are presently trying to optimise the formulation so that their effects would last even longer.

“It is conceivable we could have a formulation that is suitable for clinical trials before too long,” he says.

A research paper on their work has been published online by the Proceedings of the National Academy of Sciences. (ANI)

Russell Brand taunts Justice Secretary Jack Straw on Twitter page

London, Apr 7 (ANI): Brit comedian Russell Brand has taunted Justice Secretary Jack Straw on his Twitter page saying, “No wonder your son took drugs.”

Brand, 33, decided to take a jab at Straw, 62, after he joined others in demanding that Jonathan Ross, 48, and he pay the BBC’s 150,000 pounds fine over Sachsgate.

The actor claimed that the former Foreign Secretary should be fined for his role in leading Britain into Iraq.

“I demand Jack Straw pays the 7billion pounds he squandered on the Iraq war that we didn’t want,” the Daily Star quoted him as writing on his Twitter page.

“No wonder his son has to toke himself to sleep,” he had added.

Straw’s son William was cautioned for trying to sell cannabis to an undercover reporter in 1997 when he was 17.

There were no comments from a Ministry of Justice spokesman on the matter. (ANI)

Kasab gets a lawyer, finally

A SESSIONS court on Monday appointed 40-year-old lawyer Anjali Ramesh Waghmare to defend Mumbai terror attack accused Ajmal Amir Kasab. She is a member of the state legal aid cell panel.

The proceedings will be conducted at the Arthur Road Central Jail from April 6. Special judge M.L. Tahilyani called Waghmare to his side and told Kasab: “She (Waghmare) is your advocate and would defend you in the trial.

Aap apne lawyer ko brief kar sakte hain jab aap April 6 ko special court mein hazir honge (you can brief your lawyer when you will be produced on April 6 at the special court).” The court also informed Kasab that his lawyer had a good command over Marathi and English.

As the chargesheet were filed in these two languages, there was no need for Urdu translation of the same. Kasab had earlier demanded the chargesheet in Urdu.

Later, Waghmare said she was informed about the appointment on Monday morning. She affirmed that she was ready to accept the brief.

Waghmare told HT: “I had an intuition that I may be selected and so I was expecting the news. I am quite confident and bold enough to accept the court’s decision to defend Kasab.

“.

Rise in ‘tan jab’ use a public health concern, says editorial

London, February 18 (ANI): People are increasingly risking their health by turning to “tan jabs”, says an editorial.

Michael Evans-Brown of Liverpool John Moores University highlights the fact that drugs like Melanotan I and Melanotan II, used to tan the skin, are easily available via the Internet, tanning salons and hairdressers.

While the actual number of people having tan jabs is unknown, he says that a thriving online community of users exists.

He pointed out that the largest online community, Melanotan.org, has more than 5,000 members.

He is afraid that people using such drugs might be risking their health.

“Serious concerns exist about the quality of the preparations that are currently available – not only the drug content and dose, but also contaminants and sterility. Some users, especially those who are injecting drugs for the first time, are reusing or sharing injecting equipment, which places them and others at risk of infections, including blood borne viruses,” the British Medical Journal quoted him as saying.

Clinical trials have so far linked melanotans to only facial flushing, nausea and vomiting, one of the greatest concerns.

However, the authors of the current editorial say that one of the greatest concerns is that the drugs may interact with how the body functions, especially given that people who want to maintain a tan will be using it for a long time.

While both melanotan I and melanotan II tan the skin, the latter also causes penile erections and increases in sexual desire.

The authors argue that health professionals need to respond to this growing trend by warning patients about the dangers of using illicitly supplied drugs as well as reporting any adverse reactions.

Evans-Brown concludes that this issue will not go away given that society’s appetite for drugs for lifestyle reasons appears to be “insatiable”. (ANI)

New vaccine to protect kids against meningitis B may be available by 2011

London, Feb 11 (ANI): A new vaccine to protect kids against meningitis B may be available by 2011, according to researchers.

Although vaccines are available for pneumococcal meningitis and the “C” and “Hib” types, scientists have struggled to find an effective vaccine for meningococcus B, reports Times Online.

Now, pharmaceutical company Novartis has developed a meningococcus B vaccine, which is the frontrunner in the race to provide immunisation against the infection.

The jab is currently in the final stages of testing at the University of Oxford.

It is the first of its kind to be developed after the entire genome of a deadly bacteria was sequenced.

Rino Rappuoli, of Novartis, said the product had been developed after Craig Venter, the pioneer of human genome sequencing, published the genetic structure of meningococcus B in 2000.

This offered researchers with a lot of information about potential targets for a vaccine, or ‘antigens’, which help the body to fight off infection. (ANI)